Application 203902
- Type
- ANDA
- Sponsor
- UCSF RODIOPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | 20-300mCi/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24275-0185 | Fludeoxyglucose F18 | Fludeoxyglucose F18 | UCSF Radiopharmaceutical Facility | ANDA | Current |
| 24275-0185 | Fludeoxyglucose F18 | Fludeoxyglucose F18 | UCSF Radiopharmaceutical Facility | ANDA | Current |
| 24275-0185 | Fludeoxyglucose F18 | Fludeoxyglucose F18 | UCSF Radiopharmaceutical Facility | ANDA | Current |
| 24275-0185 | Fludeoxyglucose F18 | Fludeoxyglucose F18 | UCSF Radiopharmaceutical Facility | ANDA | Current |
| 24275-0185 | Fludeoxyglucose F18 | Fludeoxyglucose F18 | UCSF Radiopharmaceutical Facility | ANDA | Current |